Over the past few years, drugs like Ozempic and Wegovy have exploded in popularity. Marketed for blood sugar control and dramatic weight loss, respectively, these medications have been prescribed to millions of people across the United States. Alarming research has linked Wegovy and Ozempic to vision loss side effects and blindness.
Reports suggest that some patients who took either Ozempic or Wegovy have experienced sudden vision problems.
- Partial vision loss
- Blindness
Lawsuits are being filed by individuals who claim they were not adequately warned about these potential risks.
If you or a loved one experienced vision loss after using Ozempic or Wegovy, you may qualify to file an Ozempic Lawsuit. The Yost Legal Group is actively investigating these cases and assisting patients in pursuing claims against the drug manufacturers.
What are Ozempic and Wegovy?
Both Ozempic and Wegovy contain the same active ingredient: semaglutide. Semaglutide belongs to a class of medications known as GLP-1 receptor agonists. GLP 1 drugs mimic a natural hormone in the body that helps regulate blood sugar and appetite.
Although they share the same ingredient, Ozempic and Wegovy are approved for different uses:
Ozempic is FDA‑approved for adults with type 2 diabetes. It is used to improve blood sugar control and reduce the risk of major cardiovascular events such as heart attack and stroke.
Wegovy is FDA‑approved for chronic weight management in adults and adolescents aged 12 and older with obesity, or in overweight adults who have at least one weight‑related condition. It is also approved to reduce the risk of cardiovascular death, heart attack, and stroke in certain adults.
Wegovy is not specifically approved to treat diabetes. Still, some healthcare providers prescribe it as an “off‑label” use for patients with type 2 diabetes who could benefit from its weight‑loss effects.
As prescriptions for these weight loss drugs have surged, so have reports of unexpected and serious side effects – including vision problems.
Ozempic and Wegovy Linked to “Non-Arteritic Anterior Ischemic Optic Neuropathy” (NAION)
Recent medical research has raised concerns about a possible connection between semaglutide and a serious eye condition called non-arteritic anterior ischemic optic neuropathy (NAION).
NAION occurs when blood flow to the optic nerve is suddenly reduced, damaging the nerve and causing rapid loss of vision. This damage can be permanent.
A 2024 study published in JAMA Ophthalmology examined patients who were prescribed semaglutide. The study found an increased risk of NAION compared with patients taking other medications for diabetes or weight loss without semaglutide.
The authors reported that the use of semaglutide was associated with a higher incidence of this vision‑threatening condition (NAION) in certain groups of patients.
In addition, a 2025 safety review by European regulators concluded that NAION should be listed as a “very rare” side effect of semaglutide‑containing medicines, including Ozempic and Wegovy.
Regulators advised that patients who experience sudden vision loss or rapidly worsening eyesight while taking semaglutide should seek urgent medical attention.
Other reviews and safety databases have also noted increased reports of visual impairment and optic nerve problems in patients using semaglutide compared with some other medications in the same class.
Researchers are still studying exactly how semaglutide might contribute to NAION or other eye conditions.
The pattern of reports is serious enough that many patients and doctors are now asking whether they were adequately warned about these risks.
What NAION Symptoms Should Patients Watch For?
Vision loss linked to NAION can happen suddenly and without pain. People taking Ozempic or Wegovy should be alert for any changes in their eyesight, including the following:
– Sudden blurring or dimming of vision in one or both eyes
– A dark or empty area in the center of vision
– Loss of vision on one side or in a specific field of view
– Difficulty seeing in low light or upon waking up
– Sudden changes in color vision
These symptoms may appear shortly after starting the medication, after a dose increase, or even months after starting. Because NAION damages the optic nerve, time is critical.
Anyone experiencing sudden vision changes should seek emergency medical care and tell the doctor about all medications they are taking, including Ozempic or Wegovy.
Why Are Ozempic Lawsuits Being Filed?
Patients filing lawsuits against the manufacturers of Ozempic and Wegovy allege the following:
– The companies failed to adequately warn patients and doctors about the risk of serious eye injuries, including NAION, vision loss, and potential blindness.
– Important safety information was not clearly communicated in the prescribing information, marketing materials, or patient education resources.
– If patients and their healthcare providers had been adequately warned, they might have chosen different treatments, monitored vision more closely, or stopped the medication sooner.
– Drug manufacturers have a legal duty to design reasonably safe products and to provide clear, complete warnings about known or reasonably foreseeable risks.
– When a company fails to do so, and patients are harmed as a result, those patients may be entitled to compensation through a lawsuit.
People who have suffered vision loss after taking Ozempic or Wegovy may face:
– Medical bills
– Loss of independence
– Inability to work
– Emotional distress
– Long‑term disability
A medication lawsuit can help hold the manufacturers accountable and provide financial support for ongoing care and future needs.
Do You Qualify to Join an Ozempic Vision Loss Lawsuit?
Learn if you qualify to pursue a claim against the manufacturers of Ozempic or Wegovy if:
– You used Ozempic or Wegovy (semaglutide) as prescribed by your healthcare provider; and
– You were later diagnosed with a serious eye condition, such as non-arteritic anterior ischemic optic neuropathy (NAION), optic neuropathy, or other unexplained vision loss; and
– Your vision loss occurred after starting the medication, even if you also had diabetes, high blood pressure, or other risk factors.
Every case is unique. The timing of your symptoms, your medical history, and the specific drug you were prescribed all matter.
That is why it is essential to consult with an experienced law firm that understands both the medical and legal aspects involved.
How The Yost Legal Group Can Help
The Yost Legal Group has a long history of representing individuals and families harmed by dangerous drugs and medical products. Our defective drug attorneys can:
– Investigate complex medical evidence
– Work with leading experts
– Fight to hold large corporations accountable when their products cause serious harm
If you or someone you love experienced vision loss or blindness after taking Ozempic or Wegovy, The Yost Legal Group is here to help. We can:
– Review your medical and prescription history
– Consult with medical experts to evaluate whether your eye injury may be linked to semaglutide
– Explain your legal options, including the possibility of joining ongoing litigation against the drug manufacturers
– Pursue compensation for medical expenses, lost wages, pain and suffering, and other damages where appropriate
– You pay no fees or costs unless we recover compensation for you.
Contact The Yost Legal Group Today
If you have suffered vision loss or blindness after taking Ozempic or Wegovy, do not wait to get answers. Strict time limits may apply to your claim, and gathering evidence is easier when you act quickly.
Contact a product liability lawyer at The Yost Legal Group for a free, confidential consultation.
Call 800‑YOST‑LAW or (800) 967-8529.
You do not have to face this alone. Call us if you experience Ozempic side effects and develop (NAION) non-arteritic anterior ischemic optic neuropathy.
Side Effects of Ozempic – Ozempic For Weight Loss – Ozempic and Eye Problems
Semaglutide Lawsuit – Ozempic News – Ozempic FDA Warning
Ozempic Warning – Ozempic Vision Changes – Risks of Ozempic
